Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A network perspective on the ecology of gut microbiota and progression of type 2 diabetes: Linkages to keystone taxa in a Mexican cohort.
Esquivel-Hernández DA, Martínez-López YE, Sánchez-Castañeda JP, Neri-Rosario D, Padrón-Manrique C, Giron-Villalobos D, Mendoza-Ortíz C, Resendis-Antonio O. Esquivel-Hernández DA, et al. Among authors: martinez lopez ye. Front Endocrinol (Lausanne). 2023 Apr 12;14:1128767. doi: 10.3389/fendo.2023.1128767. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37124757 Free PMC article.
Effect of Insulin Resistance on Abdominal Obesity, Liver Fat Infiltration, and Body Mass Index in Youngsters.
García-Oropesa EM, Perales-Torres AL, Martínez-López YE, Munguía-Cisneros CX, Nava-González EJ, Pérez-Navarro M, Rosas-Díaz M, Baltazar N, Arroyo-Valerio A, Diaz-Badillo A, Castillo-Ruiz O, Hernández-Ruiz J, Mummidi S, Ramírez-Quintanilla LY, Bustamante A, Ramirez-Pfeiffer C, Vela L, Tapia B, Lopez-Alvarenga JC. García-Oropesa EM, et al. Among authors: martinez lopez ye. Arch Med Res. 2023 Nov;54(7):102873. doi: 10.1016/j.arcmed.2023.102873. Epub 2023 Sep 1. Arch Med Res. 2023. PMID: 37660428
On Deep Landscape Exploration of COVID-19 Patients Cells and Severity Markers.
Vázquez-Jiménez A, Avila-Ponce De León UE, Matadamas-Guzman M, Muciño-Olmos EA, Martínez-López YE, Escobedo-Tapia T, Resendis-Antonio O. Vázquez-Jiménez A, et al. Front Immunol. 2021 Sep 16;12:705646. doi: 10.3389/fimmu.2021.705646. eCollection 2021. Front Immunol. 2021. PMID: 34603282 Free PMC article.
Dysbiosis signatures of gut microbiota and the progression of type 2 diabetes: a machine learning approach in a Mexican cohort.
Neri-Rosario D, Martínez-López YE, Esquivel-Hernández DA, Sánchez-Castañeda JP, Padron-Manrique C, Vázquez-Jiménez A, Giron-Villalobos D, Resendis-Antonio O. Neri-Rosario D, et al. Among authors: martinez lopez ye. Front Endocrinol (Lausanne). 2023 Jun 27;14:1170459. doi: 10.3389/fendo.2023.1170459. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37441494 Free PMC article.
mb-PHENIX: diffusion and supervised uniform manifold approximation for denoizing microbiota data.
Padron-Manrique C, Vázquez-Jiménez A, Esquivel-Hernandez DA, Martinez Lopez YE, Neri-Rosario D, Sánchez-Castañeda JP, Giron-Villalobos D, Resendis-Antonio O. Padron-Manrique C, et al. Among authors: martinez lopez ye. Bioinformatics. 2023 Dec 1;39(12):btad706. doi: 10.1093/bioinformatics/btad706. Bioinformatics. 2023. PMID: 38015858 Free PMC article.
Effect of metformin and metformin/linagliptin on gut microbiota in patients with prediabetes.
Martínez-López YE, Neri-Rosario D, Esquivel-Hernández DA, Padron-Manrique C, Vázquez-Jiménez A, Sánchez-Castañeda JP, Girón-Villalobos D, Mendoza-Ortíz C, Reyes-Escogido ML, Evia-Viscarra ML, Aguilar-Garcia A, Resendis-Antonio O, Guardado-Mendoza R. Martínez-López YE, et al. Sci Rep. 2024 Apr 27;14(1):9678. doi: 10.1038/s41598-024-60081-y. Sci Rep. 2024. PMID: 38678119 Free PMC article.
Author Correction: Effect of metformin and metformin/linagliptin on gut microbiota in patients with prediabetes.
Martínez-López YE, Neri-Rosario D, Esquivel-Hernández DA, Padron-Manrique C, Vázquez-Jiménez A, Sánchez-Castañeda JP, Girón-Villalobos D, Mendoza-Ortíz C, Reyes-Escogido ML, Evia-Viscarra ML, Aguilar-Garcia A, Resendis-Antonio O, Guardado-Mendoza R. Martínez-López YE, et al. Sci Rep. 2024 Sep 10;14(1):21124. doi: 10.1038/s41598-024-72292-4. Sci Rep. 2024. PMID: 39256606 Free PMC article. No abstract available.
Looking for Crumbs in the Obesity Forest: Anti-obesity Interventions and Obesity-Associated Cardiometabolic Traits in the Mexican Population. History and Systematic Review With Meta-Analyses.
Garcia-Oropesa EM, Martinez-Lopez YE, Ruiz-Cejudo SM, Martínez-Ezquerro JD, Diaz-Badillo A, Ramirez-Pfeiffer C, Bustamante-Fuentes A, Lopez-Sosa EB, Moctezuma-Chavez OO, Nava-Gonzalez EJ, Perales-Torres AL, Perez-Navarro LM, Rosas-Diaz M, Carter K, Tapia B, Lopez-Alvarenga JC. Garcia-Oropesa EM, et al. Front Med (Lausanne). 2021 Nov 3;8:665023. doi: 10.3389/fmed.2021.665023. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34805192 Free PMC article.
The combination of linagliptin, metformin and lifestyle modification to prevent type 2 diabetes (PRELLIM). A randomized clinical trial.
Guardado-Mendoza R, Salazar-López SS, Álvarez-Canales M, Farfán-Vázquez D, Martínez-López YE, Jiménez-Ceja LM, Suárez-Pérez EL, Angulo-Romero F, Evia-Viscarra ML, Montes de Oca-Loyola ML, Durán-Pérez EG, Folli F, Aguilar-García A. Guardado-Mendoza R, et al. Metabolism. 2020 Mar;104:154054. doi: 10.1016/j.metabol.2019.154054. Epub 2019 Dec 28. Metabolism. 2020. PMID: 31887309 Clinical Trial.
15 results